Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
A&P to host 'Healthcare Joint Ventures and Transactions' webcast series
Arnold & Porter LLP will host the first of a three-part webcast series, “Healthcare Joint Ventures and Transactions: A Response to the Changing Healthcare Payment and Delivery Landscape,” on June 16.
Bookings for commercial liver tissue reach nearly $2 million
Organovo Holdings, Inc. announced financial results for fiscal 2015 and revealed that its commercial liver tissue product exVive3D Human Liver Tissue, has acquired approximately $1.94 million in contract bookings to date, according to a press release.
Log in or Sign up for Free to view tailored content for your specialty!
Boston Children's Hospital named best children's hospital for gastroenterology, GI surgery
Boston Children’s Hospital has been ranked the No. 1 children’s hospital in the nation for gastroenterology and GI surgery, according to the 2015-2016 edition of “U.S. News & World Report’s Best Children's Hospitals” survey.
Nexavar/HAIC with cisplatin yields favorable results for HCC
CHICAGO — In a randomized phase 2 trial, treatment with Nexavar plus hepatic arterial infusion chemotherapy with cisplatin yielded better results vs. treatment with Nexavar alone for patients with advanced hepatocellular carcinoma, according to a poster presented at the ASCO Annual Meeting.
Over 95% of global population suffer from health problems
Only 4.3% of the world’s population have no health issues, with growth in the aging population potentially playing a part in the significant increase of illness, according to recently released data from The Lancet.
Researchers find Inlyta/TACE safe, well-tolerated in Chinese patients with HCC
CHICAGO — In an ongoing phase 2 clinical trial, Inlyta and transarterial chemoembolization therapy was safe and yielded high response rates in Chinese patients with hepatocellular carcinoma, according to a poster presented at the ASCO Annual Meeting.
Fungus found in NIH pharmaceuticals, manufacturing suspended
Following the FDA’s discovery of several deficiencies in manufacturing and operating procedures, the NIH has suspended operations of its Pharmaceutical Development Center until further notice, according to a press release.
Calculating workforce size is especially important for employers
Most employers have fewer than 50 full-time employees or full-time equivalent employees. Therefore, they are not subject to the Affordable Care Act’s employer shared-responsibility provision.
Exalenz initiates trial of BreathID test for diagnosing HCC
Exalenz Biosciences announced a clinical trial is underway to investigate whether its BreathID test is useful in diagnosing hepatocellular carcinoma, according to a press release from the manufacturer.
CMS releases new Medicare Part B reimbursement data
The annual update on physicians’ Medicare Part B reimbursement, and the data showed that nearly $90 billion in Medicare payments was paid out to over 950,000 health care providers across all 50 states, Washington, D.C. and Puerto Rico.
-
Headline News
'Chroming': Dangerous huffing trend gains popularity on TikTok, led by minors
September 27, 20242 min read -
Headline News
FDA approves first new class of schizophrenia treatment in more than 30 years
September 27, 20243 min read -
Headline News
Follow the twists and turns toward better kidney care — more on the road ahead
September 27, 20241 min read
-
Headline News
'Chroming': Dangerous huffing trend gains popularity on TikTok, led by minors
September 27, 20242 min read -
Headline News
FDA approves first new class of schizophrenia treatment in more than 30 years
September 27, 20243 min read -
Headline News
Follow the twists and turns toward better kidney care — more on the road ahead
September 27, 20241 min read